ACCUSTEM SCIENCES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ACCUSTEM SCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $0.00.
- ACCUSTEM SCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00.
- ACCUSTEM SCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $0.00.
- ACCUSTEM SCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $1.58M.
- ACCUSTEM SCIENCES, INC. stock issued during period, value, new issues for fiscal 2025 was $1.58M, a 575.54% increase from fiscal 2024.
- ACCUSTEM SCIENCES, INC. stock issued during period, value, new issues for fiscal 2024 was $233.74K.
- ACCUSTEM SCIENCES, INC. stock issued during period, value, new issues for fiscal 2022 was $2.68M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $1.58M 10-K · filed 2026-04-14 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | |
| 2025-03-31 | $1.58M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $233.74K 10-K · filed 2026-04-14 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $2.68M 10-K · filed 2024-03-22 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | |
| 2022-03-31 | $2.68M 10-Q · filed 2023-05-05 |